R&R, Inc.
🇺🇸United States
Phase II Study of RR110 in Patients With Active Crohn's Disease
Phase 2
Completed
- Conditions
- Crohn's Disease
- Interventions
- Drug: RR110 (Tamibarotene)
- First Posted Date
- 2007-01-01
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- R&R Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00417391
© Copyright 2025. All Rights Reserved by MedPath